. Anomeric proton signal of 1 H-NMR spectrum for Table 1 , entry 6.
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Synthesis of an authentic sample of 4β. 2´-Deoxy-3´,5´-bis-O-(tert-butyldimethylsilyl)thymidine (386 mg, 1.0 mmol) was dissolved in anhydrous pyridine (3 mL) and the solution was cooled to 0 °C. Benzoyl chloride (155 mg, 1.1 mmol) was then added under argon and the mixture was warmed to room temperature. The reaction mixture was stirred at room temperature for 21 h under argon and then diluted with EtOAc (30 mL). The organic layer was washed with water (3 x 30 mL), dried over anhydrous Na 2 SO 4 , filtered, and concentrated under reduced pressure.
The residue was purified by flush column chromatography on a silica gel (C-300, 30 g) column, eluting with gradient 15% EtOAc in n-hexane to afford 1-3β as white solid (229 mg, 0.40 mmol, 40%). 5, 162.4, 149.0, 136.6, 135.6, 131.1, 130.4, 129.5, 109.6, 87.0, 84.5, 71.8, 62.6, 25.8, 18.1, 17.7, 12.2, -4.7, -5.4 Table 1 , entry 6.
9-(3,5-Bis-O-(tert-butylsilyl)-2-deoxy-D-ribofuranosyl)-6-chloropurine (5α, 5β)
6-chloropurine (77 mg, 0.50 mmol) and 2 (544 mg, 1.5 mmol), tri(n-butyl)phosphine (374 μL, 1.5 mmol) and 1,1´-(azodicarbonyl)dipiperidine (379 mg, 1.5 mmol) were reacted according to the above general procedure. The purification by a silica gel (C-300, 50 g) column chromatography eluting with gradient 30% EtOAc in n-hexane to afford a mixture of 5α and 5β and as yellow oil (150 
2´-deoxy-3´,5´-bis-O-(tert-butylsilyl)thymidine (6α and 6β)
Thymine (63 mg, 0.50 mmol), 2 (544 mg, 1.5 mmol), tri(n-butyl)phosphine (374 μL, 1.5 mmol) and 1,1´-(azodicarbonyl)dipiperidine (379 mg, 1.5 mmol) were reacted according to the above general procedure. The purification by flush column chromatography on a silica gel (C-300, 60 g) column, eluting with gradient 30% EtOAc in n-hexane gave a mixture of 6β and6α as colorless oil (43 mg, 0.091 mmol, 18%, β:α = 50:50). The 1 H-NMR were measured using the CDCl 3 solution, and analyzed by the comparison with those of those reported in the literature.
13
2´-deoxy-3´,5´-bis-O-(tert-butylsilyl)adenosine (7α and 7β) Adenine (67.6 mg, 0.50 mmol), 2 (544 mg, 1.5 mmol), tri(n-butyl)phosphine (374 μL, 1.5 mmol) and 1,1´-(azodicarbonyl)dipiperidine (379 mg, 1.5 mmol) were reacted according to the above general procedure. The purification by flush column chromatography on a silica S4 gel (C-300, 30 g) column, eluting with gradient 5% MeOH in dichloromethane gave a mixture of 7β and 7α as colorless oil (156 mg, 0.31 mmol, 65%, β:α = 70:30 ). The NMR spectra were identical with those of reported in the literature. 38, 123.47, 111.74, 110.08, 108.19, 91.49, 89.26, 73.03, 63.34, 42.88, 25.98, 25.68, 18.41, 17.90, -4.77, -4.89, -5 
2-N-Acetyl-7-deaza-2´-deoxy-7-iodo-6-O-(N,N-diphenylcarbamoyl)-3´,5´-bis-O-(tert-b utyldimethylsilyl)guanosine (1α, 1β)
2-N-Acetyl-7-deaza-7-iodo-6-O-(N,N-diphenylcarbamoyl)guanine (1.15 g, 2.24 mmol), 2 (2.44 g, 6.71 mmol), tri(n-butyl)phosphine (1.66 mL, 6.71 mmol) and 1,1´-(azodicarbonyl)dipiperidine (4.70 g 6.71 mmol) were reacted according to the above general procedure. The purification by flush column chromatography on a silica gel (N-60, 200 g) column, eluting with gradient 30% EtOAc in n-hexane gave 1β (1.18 g, 1.37 mmol, 61%) and 1α (439 mg, 0.51 mmol, 23%) as yellowish solids. 157.0, 153.9, 151.7, 150.6, 141.6, 130.5, 129.3, 128.2, 126.6, 107.7, 87.1, 83.3, 72.3, 62.8, 52.2, 25.8, 25.7, 24.5, 18.0, 17.7, -4.8, -4 7, 157.0, 153.7, 151.8, 150.7, 141.5, 131.3, 129.3, 128.2 126.6, 107.3, 88.6, 83.8, 72.7, 62.9, 51.7, 25.8, 25.7, 24.6, 17.9, 17.4, -5.3, -5.1, -5.5, -5.5 
3´,5´-bis-O-(tert-butyldimethylsilyl)-2´-deoxy-5-fluorouridine (12α and 12β) N
3
-benzoyl-5-fluorouracil (117 mg, 0.50 mmol), 2 (544 mg, 1.5 mmol), tri(n-butyl)phosphine (374 μL, 1.5 mmol) and 1,1´-(azodicarbonyl)dipiperidine (379 mg1.5 mmol) were reacted according to the above general procedure. The reaction mixture was purified by flush column chromatography on a silica gel (C-300, 50 g) column, eluting with 15% EtOAc in n-hexane to afford a mixture of the fully protected nucleosides and 2 as colorless oil. Then, the mixture was dissolved in ethanol (7.5 mL) and 28% NH 3 aq. (2.5 mL) was added. After reaction mixture was stirred at 55 °C, the solvents were removed under reduced pressure. The residue was purified by flush column chromatography on a silica gel (C-300, 50 g) column, eluting with gradient 30% EtOAc in n-hexane to afford 12β as white solid (140 mg, 0.29 mmol, 59%) and 12α as colorless oil (58 mg, 0.12 mmol, 24%). 41, 157.20, 149.19, 141.55, 139.67, 124.60, 124.34, 124.10, 88.23, 88.04, 85.64, 85.53, 71.61, 71.46, 62.87, 62.75, 62.71, 62.57, 42.04, 41.87, 41.75, 26.17, 26.05, 25.92, 25.89, 25.80, 25.75, 25.61, 18.51, 18.08, -4.48, -4.56, -4.74, -4.82, -5.43, -5.46, -5.52, -5.55 39, 157.17, 149.22, 141.07, 139.20, 126.00, 125.97, 125.73, 125.70, 90.87, 90.82, 87.63, 87.58, 73.00, 72.99, 63.58, 41.45, 25.99, 25.68, 18.40, 17.95, -4.77, -4.82, -4.84, -4.88, -5.33, -5.37, -5 
